Sphingosine-1-phosphate Receptor Agonism ReducesBordetella pertussis–mediated Lung Pathology

Epithelial Anion Transporter Pendrin Contributes to Inflammatory Lung Pathology in Mouse Models of Bordetella pertussis Infection

(2014) Karen M. Scanlon et al.   INFECTION AND IMMUNITY

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen

(2014) C. Skerry et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?

(2014) C. M. Ausiello et al.   mBio

The Virulence Factors of Bordetella pertussis: Talented Modulators of Host Immune Response

(2013) Giorgio Fedele et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

(2013) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Critical Pertussis Illness in Children

(2013) John T. Berger et al.   Pediatric Critical Care Medicine

Pertussis Toxin Exacerbates and Prolongs Airway Inflammatory Responses during Bordetella pertussis Infection

(2012) Carey E. Connelly et al.   INFECTION AND IMMUNITY

Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection

(2011) John R. Teijaro et al.   CELL

Sphingosine-1-phosphate signaling and its role in disease

(2011) Michael Maceyka et al.   TRENDS IN CELL BIOLOGY

Fulminant pertussis: A multi-center study with new insights into the clinico-pathological mechanisms

(2009) Mohammad Sawal et al.   PEDIATRIC PULMONOLOGY